Connecticut’s business climate is taking another hit, with word Bristol Myers-Squibb is closing its Wallingford facility and leaving the state by the end of 2018. That means 500 jobs will disappear with the pharmaceutical giant’s departure.
“We are in the process of evaluating the roles and work within our functions based on changes to the needs of our business, our geographic presence and broader decisions in support of our company’s transformation,” Ken Dominski, a company spokesman said in a written statement. “Following the close of Wallingford, we will no longer have a site in Connecticut.
Dominski would not venture the amount of jobs that would be lost, but 500 were working at the facility, down from 900, when the firm relocated its research and development jobs out of state.